Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
October 13th, 2025 |
RFA-TP-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-EH-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-CE-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-DP-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-CK-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-IP-18-000 |
Centers for Disease Control and Prevention ERA |
February 20th, 2024 |
Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required) |
National Institutes of Health |
October 13th, 2025 |
RFA-PS-18-000 |
Centers for Disease Control and Prevention ERA |
January 7th, 2027 |
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) |
National Institutes of Health |
November 19th, 2024 |
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
December 19th, 2023 |
HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed) |
National Institutes of Health |
December 19th, 2023 |
HEAL Initiative: Limited Competition: Data Coordinating Center for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
October 23rd, 2024 |
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) |
National Institutes of Health |
October 13th, 2025 |
RFA-SH-18-000 |
Centers for Disease Control and Prevention ERA |
February 15th, 2024 |
Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
October 13th, 2025 |
RFA-TS-18-000 |
Centers for Disease Control and Prevention ERA |
March 13th, 2025 |
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
March 13th, 2025 |
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 8th, 2024 |
Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
November 16th, 2024 |
Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
|
April 18th, 2024 |
Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional) |
National Institutes of Health |
December 18th, 2023 |
Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional) |
National Institutes of Health |
December 18th, 2023 |
ROSS (Resident Opportunity and Self-Sufficiency) Service Coordinator Program - FY2023 - NOFO |
Department of Housing and Urban Development |
December 4th, 2024 |
Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional) |
National Institutes of Health |
October 13th, 2025 |
RFA-GH-18-000 |
Centers for Disease Control and Prevention ERA |
October 13th, 2025 |
RFA-DD-18-000 |
Centers for Disease Control and Prevention ERA |
January 6th, 2027 |
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) |
National Institutes of Health |
January 6th, 2027 |
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) |
National Institutes of Health |
November 15th, 2023 |
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) |
National Institutes of Health |
December 8th, 2023 |
Ending Neglected Diseases through Operational Research (ENDOR) |
Agency for International Development |
March 20th, 2024 |
Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
January 16th, 2024 |
Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among |
Centers for Disease Control and Prevention ERA |
March 1st, 2024 |
A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison |
Centers for Disease Control and Prevention ERA |
February 8th, 2024 |
Understanding Infant Feeding Preferences, Practices, and Outcomes for Mothers and other Parents with HIV in the United States |
Centers for Disease Control and Prevention ERA |
February 26th, 2024 |
Improving the Quality of Life of People with HIV Aged 50 Years and Older in the United States |
Centers for Disease Control and Prevention ERA |
March 13th, 2024 |
Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
September 30th, 2025 |
Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
October 13th, 2026 |
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 21st, 2024 |
Integrated Data Management and Analysis for Informed Public Health Decision-Making in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 21st, 2024 |
Enhancing HIV Prevention, Care and Treatment Services through Patient Empowerment, Community Engagement and Improved Public Health Information Systems in Ukraine under the President's Emergency Plan for AIDS Relief |
Centers for Disease Control CGH |